Robert F. Kennedy, Jr., President Donald Trump’s nominee for secretary of the US Department of Health and Human Services, faced scrutiny from senators regarding his potential financial interests in vaccine litigation, particularly involving the HPV vaccine Gardasil.
During confirmation hearings, concerns were raised about Kennedy's history of casting doubt on vaccines and the possibility of financial gain from such actions. Democratic senators Ron Wyden and Elizabeth Warren expressed unease over Kennedy's extensive involvement and financial ties to vaccine-related litigation.
